Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Mol Cancer ; 8: 55, 2009 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-19646247

RESUMO

BACKGROUND: Deproteinized DNA from eukaryotic and prokaryotic cells still contains a low-molecular weight peptidic fraction which can be dissociated by alkalinization of the medium. This fraction inhibits RNA transcription and tumor cell growth. Removal from DNA of normal cells causes amplification of DNA template activity. This effect is lower or absent in several cancer cell lines. Likewise, the amount of active peptides in cancer cell DNA extracts is lower than in DNA preparation of the corresponding normal cells. Such evidence, and their ubiquitous presence, suggests that they are a regulatory, conserved factor involved in the control of normal cell growth and gene expression. RESULTS: We report that peptides extracted from wheat bud chromatin induce growth inhibition, G2 arrest and caspase-dependent apoptosis in HeLa cells. The growth rate is decreased in cells treated during the S phase only and it is accompanied by DNA damage and DNA synthesis inhibition. In G2 cells, this treatment induces inactivation of the CDK1-cyclin B1 complex and an increase of active chk1 kinase expression. CONCLUSION: The data indicate that the chromatin peptidic pool inhibits HeLa cell growth by causing defective DNA replication which, in turn, arrests cell cycle progression to mitosis via G2 checkpoint pathway activation.


Assuntos
Apoptose/efeitos dos fármacos , Ciclo Celular/efeitos dos fármacos , Proteínas de Ligação a DNA/farmacologia , Fase G2/efeitos dos fármacos , Peptídeos/farmacologia , Proteínas de Plantas/farmacologia , Triticum/química , Proteína Quinase CDC2/metabolismo , Processos de Crescimento Celular/efeitos dos fármacos , Cromatina/metabolismo , Ciclina B/metabolismo , Ciclina B1 , Dano ao DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/isolamento & purificação , Proteínas de Ligação a DNA/metabolismo , Células HeLa , Humanos , Peptídeos/isolamento & purificação , Peptídeos/metabolismo , Proteínas de Plantas/isolamento & purificação , Proteínas de Plantas/metabolismo , Fase S/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa